The partnership brings together Salipro’s tech for stabilising drug targets from Boehringer’s drug discovery programmes.

AstraZeneca’s senior director in oncology data science outlined how the company uses AI for drug discovery at a recent talk.

Stanford Medicine researchers have identified a naturally occurring molecule that mimics the appetite-suppressing effects of ...

Insilico Medicine has completed a Series E round, raising $110m to progress the development of its pipeline of drugs and AI ...

The New Normal Five years ago, COVID-19 was declared a global pandemic, marking the official onset of a healthcare crisis ...

Antibiotic resistant bacteria are one of the greatest challenges facing modern medicine, and they are likely to grow greater ...

In essence, the future of AI is inextricably linked to advancements in data management, making it an indispensable enabler of ...

The immune system typically can ramp up the body's defenses to clear out an invading threat without issue. Glitches can ...

Scientists have discovered a naturally occurring molecule that aids appetite control and weight loss so well, it may compete ...

Having found that in biomedical research, the Bird Rock resident and scientist at La Jolla’s Sanford Burnham Prebys has ...

Pheiron and Ribo are excited to announce that the first two strategic collaboration milestones have been successfully ...

AI-powered tools like Merck’s Aiddison can accelerate drug identification and optimise design, cutting both costs and time to ...